1. Field of the Invention
The present invention relates to compositions of matter which comprise diacylglycerol(s) (DAG), mainly 1,3-diacylglycerol(s), and phytosterol and/or phytostanol ester(s) (PSE) and optionally monoglycerides, dissolved or dispersed in edible oil and/or edible fat, to their preparation and various uses, particularly as dietary nutrients, as food supplements and/or as ingredients in the food industry.
More specifically, the present invention relates to products of alcoholysis, esterification and/or interesterification of phytosterol(s) and/or phytostanol(s) in oil using an immobilized, optionally surfactant-coated, lipase. In particular, the invention relates to new mixtures of phytosterol and/or phytostanol ester(s) in edible oil and/or fat. Such mixtures usually comprise an oily fraction that contains, inter alia, diacylglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly unsaturated fatty acids, and a paste-like fraction that contains diacylglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly saturated fatty acids. The present invention further provides a variety of novel, enriched mixtures of diglyceride(s) and phytosterol and/or phytostanol ester(s) in oil or fat, obtained by further fractionation of the mixtures of the invention. The present invention further relates to highly purified phytosterol and/or phytostanol ester(s) and mixtures of esters obtained by the said fractionation process.
2. Prior Art
The term “phytosterols” covers plant sterols and plant stanols. Plant sterols are naturally occurring substances present in the diet as minor components of vegetable oils. Plant sterols have a role in plants similar to that of cholesterol in mammals, e.g. forming cell membrane structures. In human nutrition, both free plant sterols and free plant stanols are beneficiary.
Phytosterols and phytosterol esters are currently being used in three main industrial categories, namely pharmaceuticals, cosmetics and alimentary products. In human nutrition, phytosterols have been shown to reduce serum cholesterol and thus reduce the risk of cardiovascular diseases (CVD) [Pollak, 0. J. (1953) Circulation, 7, 702-706]. Since phytosterols are not fat-soluble, esterification processes were developed for producing fat-soluble phytosterol esters. Available common foods that contain phytosterol esters are mainly oils, margarines and to some extent dairy products. Many other current food products contain phytosterol esters, inter alia, pasta and chocolate products, to name but few. Incorporation of phytosterol esters in nutritional products appears to be of significance, and easily provides dietary alternatives for serum cholesterol reduction preventive therapy in a normal population in the case of preliminary cholesterolemia and, in combination with statins, in severe hypercholesterolemia.
Diglycerides (DAG)
Diglycerides contain only two fatty acids per molecule of fat, instead of three. The major part of the two fatty acids are located mainly on each end of the fat molecule (generally referred as 1,3 positions). In nutrition, this composition of diglycerides with the unique position of fatty acids is of significant difference. The body digests DAG oil same as a conventional oil. However, one of the digestion components is different, due to the original position of the two fatty acids on the DAG oil. The gut does not prefer to reassemble fat-rich particles using this digestion component, and this is reflected by a lower number of fat-rich particles in the blood following a meal containing DAG oil. As a result, the digestion component is completely disassembled in the gut. This difference leads the body to use this portion of the fatty acids for energy rather than fat storage following absorption. Further study of DAG oil in humans showed that following consumption of as little as 20 grams of DAG oil, the number of fat-rich particles in the blood was observed to decrease compared to conventional oil (Taguchi, H., et al., J Am Coll Nutr (November-December 2000) 19(6):789-96). The level of fat-rich particles following DAG oil consumption is approximately 50% less than conventional oil at the peak level of fat-rich particles after a meal. As researchers understand the impact of post-meal fat levels on blood vessel health, this aspect of DAG oil could be even more beneficial. In people with high, particularly excess body weight and body mass index (BMI), long-term consumption of DAG oil may affect body weight and body fat changes. Initial studies indicate that body weight and body fat losses may occur to a greater extent when consuming 10-25 grams of DAG oil per day in place of conventional oil (Nagao, T., et al., J Nutr (2000) 130(4):792-7). DAG oil has been approved by the Japanese government for specific health uses pertaining to post-meal blood lipids and body weight. Additionally, a professional association of Japanese physicians has officially recommended DAG oil as part of a healthy diet. In the United States, DAG oil is generally recognized as safe (GRAS) by an expert panel review and can be marketed as a cooking oil and spread. Initial study indicates that body weight and total fat mass changes may respond in the same beneficial manner in overweight adult American individuals (FASEB J (2001) 15(4):A301) as with Japanese individuals.
WO01/32035 teaches olive oil-based products, based on especially higher grades of olive oils (such as virgin olive oils), comprising plant stanol esters and/or plant sterol esters.
U.S. Pat. No. 5,843,499 discloses oil extractable from corn fiber that contains ferulate esters (phytosterol esters which are esterified to ferulic acid), in particular sitostanyl ester, which has been shown to have cholesterol-lowering activity. It is mentioned that corn fiber oil (containing about 73% fat (triacylglycerol), 8% sterol (fatty acyl) esters, 4% free sterols, 6% diacylglycerols and 6% ferulate (sterol esters) is used as an additive to supplementary food for reducing cholesterol level.
U.S. Pat. No. 6,326,050 discloses a composition consisting of oil or fat, a diacylglycerol, a free phytosterol and tocopherol, dissolved or dispersed in the oil or fat.
None of the above mentioned publications have described a combination of phytosterol ester and diacylglycerol in oil and/or fat.
Furthermore, the prior art does not describe the enrichment of any naturally occurring oil or fat with diglycerides and phytosterol or phytostanol esters.
WO01/75083 describes a process for selective alcoholysis or esterification (interesterification) of free sterols (including phytosterols) in a fat-based product, using an immobilized, optionally surfactant-coated, lipase. The reaction takes place in the presence of triglycerides contained in the fat-based product, optionally following addition of at least one carboxylic fatty acid or ester derivative thereof. As defined in this publication, “selective alcoholysis” means that the process causes alcoholysis or esterification of the free sterol, without causing a significant change in the identity or positional distribution of the fatty acyl groups on the glycerol backbone of the triglycerides present in the oil- or fat-based product, e.g. butterfat. This publication describes modified butterfat compositions and low-cholesterol food preparations obtained by the described process, and further describes the in situ obtained fat-based products enriched with phytosterol esters. However, WO 01/75083 does not provide any details of the composition and constituents of the products obtained by the said selective esterification reaction or their physical properties, neither does it teach or suggest specific enrichment steps of the products obtained, for improved uses of the obtained combinations of diacylglycerol(s) and phytosterol and/or phytostanol ester(s) or the corresponding enriched products.
In view of the above, it is an object of present invention to provide an edible composition consisting of phytosterol and/or phytostanol ester(s) and diacylglycerol(s) in oil and/or fat, which may further optionally comprise monoglycerides.
It is a further object of present invention to provide the said composition as a dietary nutritional supplement (food additive) or as an ingredient in alimentary products.
It is yet a further object of present invention to prepare the said composition by either enzymatic interesterification of phytosterol(s) and/or phytostanol(s), where the triglycerides contained in the oil and/or fat serve as acyl donors, or by just mixing or blending phytosterol and/or phytostanol ester(s) and diacylglycerol(s) with the oil and/or fat.
It is yet another object of the present invention to provide a mixture of diacylglyceride(s) and phytosterol and/or phytostanol ester(s) in oil or fat, which may be further fractionated for further enrichment.
It is another object of present invention to provide a variety of enriched mixtures of diglyceride(s) and phytosterol and/or phytostanol ester(s) of saturated fatty acids.
It is yet a further object of present invention to provide a variety of enriched mixtures of diglyceride(s) and phytosterol and/or phytostanol ester(s) of unsaturated fatty acids.
It is yet another object of present invention to provide highly purified phytosterol and/or phytostanol esters.
It is a further object of the present invention to provide a process for preparing a composition consisting of phytosterol and/or phytostanol ester(s) and diglycerides, of pre-determined composition, in oil and/or fat
These and other objects of the invention will become apparent as the description proceeds.
The invention relates to a composition of matter comprising at least one diacylglycerol and at least one phytosterol and/or phytostanol ester dissolved or dispersed in an edible oil and/or edible fat.
The composition of matter according to the invention preferably comprises from 1 to 99 wt % diacylglycerol(s) and from 1 to 99 wt % phytosterol and/or phytostanol ester(s) dissolved or dispersed in edible oil and/or edible fat, and may further optionally comprise monoglycerides.
In particular embodiments, the composition of matter according to the invention comprises 1 to 99 wt % diacyglycerols, from 1 to 99 wt % phytosterol and/or phytostanol esters and from 0 to 50 wt % monoglycerides and from 1 to 99 wt % triacyglycerol (s). More particularly, the composition of matter according to the invention comprises from 3 to 50 wt % diacyglycerols, from 7 to 48 wt % phytosterol and/or phytostanol esters and from 2 to 90 wt % triacyglycerol(s).
The phytosterol esters may be selected from the group consisting of beta-sitosterol, campesterol, stigmasterol and brassicasterol esters. The phytostanol esters may be selected from the group consisting of stigmasterol, campestanol and sitostanol.
In particular embodiments, the said phytosterol and/or phytostanol esters are esters of C14-C22, preferably C16-C18 saturated or unsaturated fatty acids, particularly oleic, linoleic, linolenic, palmitic and stearic acids.
The diacylglycerol(s) are preferably 1,3-di-fatty acyl glycerol(s).
The edible oil base is preferably selected from the group consisting of linseed oil, rapeseed oil, corn oil, olive oil, cocoa butter, rice brain oil, soybean oil, palm oil, kernel oil, castor oil, cotton seed oil, coconut oil, peanut oil, sunflower oil, avocado oil, safflower oil and fish oil
The edible fat is preferably selected from the group consisting of butterfat and animal fat, particularly lard.
In a further embodiment, the invention relates to a dietary food supplement and alimentary products comprising the composition of matter according to the invention.
In yet a further embodiment, the invention provides a process for preparing a composition of matter according to the invention, which process comprises the step of esterifying the phytosterol(s) and/or phytostanol(s) in oil and/or fat to give a product (referred to as Mixture A) consisting of phytosterol and/or phytostanol esters and diglycerides in oil and/or fat, wherein said product comprises two visibly distinct fractions being an oil fraction comprising diacylglycerol(s), triacylglycerol(s) and phytosterol and/or phytostanol esters of mainly unsaturated fatty acid(s) and a paste-like fraction comprising diacylglycerol(s), triacylglycerol(s) and phytosterol and/or phytostanol esters of mainly saturated fatty acid(s).
In the process of the invention, said oil fraction contains about 10-20% by weight of phytosterol and/or phytostanol esters of mainly unsaturated fatty acid(s) and said paste-like fraction contains about 30-35% by weight of phytosterol and/or phytostanol esters of mainly saturated fatty acid(s).
The phytosterol and/or phytostanol esters employed in the process of the invention are esters of C14-C22, preferably C16-C18 saturated or unsaturated fatty acids, particularly oleic, linoleic, linolenic, palmitic and stearic acids. Particular phytosterols are selected from the group consisting of beta-sitosterol, campesterol, stigmasterol, brassicasterol, and particular phytostanols are selected from the group consisting of campestanol and sitostanol.
In another embodiment, the invention relates to a process for obtaining a product containing ester(s) of phytosterols and/or phytostanols with saturated or unsaturated fatty acids, said process comprising the steps of (a) esterifying phytosterol(s) and/or phytostanols in oil and/or fat to give a first product (referred to as Mixture A), said first product comprising two visibly distinct fractions, the first fraction being an oil fraction which comprises diacylglycerol(s), triacylyglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly unsaturated fatty acid(s), and the second fraction being a paste-like fraction which comprises diacylglycerol(s), triacylyglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly saturated fatty acid(s), and (b) separating the two fractions of said Mixture A, to give a first product (referred to as Mixture B) which comprises diacylglycerol(s), triacylyglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly saturated fatty acids and a second product (referred to as Mixture C) which comprises diacylglycerol(s), triacylyglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly unsaturated fatty acids are obtained.
The separation of the two fractions of Mixture A may be carried out by centrifugation.
The content of phytosterol and/or phytostanol esters in Mixture B may be further enriched to form a product (referred to as Mixture B1) comprising at least 50% by weight of phytosterol and/or phytostanol esters of mainly saturated fatty acids. Thus, Mixture B may be enriched by treatment with hexane, or it may be enriched by treatment with toluene, to give substantially pure phytosterol and/or phytostanol esters (at least 98% by weight) of mainly saturated fatty acids (referred to as Mixture B2).
The content of phytosterol and/or phytostanol esters in said Mixture C may be further enriched to give a product (referred to as Mixture C1) comprising at least 25% by weight of phytosterol and/or phytostanol esters of mainly unsaturated fatty acids. Thus, Mixture C may be enriched by treatment with acetone, or by treatment with toluene, to give pure phytosterol and/or phytostanol esters (at least 95% by weight) of mainly unsaturated fatty acids (referred to as Mixture C2).
The invention further relates to said mixture B, mixture B1, mixture B2, mixture C, mixture C1 and mixture C2, particularly when obtained by the process of claims 20 and 22.
Still further, the invention relates to a dietary nutrient, alimentary product or food supplement, which comprises diacylglycerol(s), triacylyglycerol(s) and phytosterol and/or phytostanol ester(s) of mainly unsaturated fatty acid(s) and/or of mainly saturated fatty acid(s). The dietary nutrient, alimentary product or food supplement, may further comprise monoglycerides.
The invention also relates to said dietary nutrient, alimentary product or food supplement, in dosage unit form, preferably a tablet or capsule.
The dietary nutrient or alimentary product according to the invention may be any one of low-cholesterol butter, cocoa butter, anhydrous milk fat, ice cream, coffee whitener and cream, dairy product, particularly cheese and other cholesterol-containing foods.
The present invention will be more clearly understood from the detailed description of the preferred embodiments and from the attached drawings in which:
In search for a still more beneficiary food supplement, the inventors have surprisingly arrived at a combination of diacyl glycerol(s), mainly 1,3-diacyl glycerol(s) (DAG) and phytosterol and/or phytostanol ester(s) (PSE) in oil and/or fat base, which is an object of the present invention. While various combinations of phytosterols and diglycerides were known (e.g. said U.S. Pat. No. 6,326,050), the combination of phytosterol ester(s) and diacylglycerol(s) is novel, and was unexpectedly found to have several advantages over known combinations of diacylglycerol(s) and free phytosterol. Thus, using phytosterol esters instead of the conventional free phytosterols, it is easier to increase their concentration in the mixture. Additionally, crystalline plant sterols do not to a significant degree dissolve in the micelli phase in the alimentary canal, and are therefore not capable of efficiently inhibiting cholesterol absorption. Moreover, oils and fats are only to a limited degree capable of dissolving free sterols. Only in a dissolved form do sterols inhibit the absorption of cholesterol.
Thus, the main feature of the present invention is a composition consisting essentially of diacylglycerol(s) and phytosterol and/or phytostanol ester(s) dissolved or dispersed in edible or oil and/or edible fat base. The composition of the present invention may be useful as a dietary nutrient, as a food supplement and/or as an ingredient in the food industry.
The compositions of the invention may be obtained, e.g., by using the selective alcoholysis or (inter)-esterification process described in WO01/75083. It has now been found that the oil product which may be obtained by the selective phytosterol esterification as described in WO 01/75083 or a similar process, consists of two fractions, each of which contains diglyceride(s) and a different type of phytosterol and/or phytostanol ester(s). More particularly, the selective alcoholysis or interesterification product is a mixture constituted of two fractions (oil and paste), wherein the phytosterol and/or phytostanol ester(s) of saturated fatty acids are substantially contained in one fraction, while esters of unsaturated fatty acids are substantially contained in the other fraction.
Thus, the present invention further provides a process for preparing said composition, which process comprises an esterification step of phytosterol(s) and/or phytostanol(s) in oil and/or fat, to produce a product (referred to as Mixture A) consisting of phytosterol and/or phytostanol esters and diglycerides in said oil and/or fat. This product comprises two visibly distinct fractions (layers), namely an oil fraction which contains diglycerides, triglycerides and phytosterol and/or phytostanol esters of mainly unsaturated fatty acid(s), and a paste-like fraction (spread) which contains diglycerides, triglycerides and phytosterol and/or phytostanol esters of mainly saturated fatty acid(s). The two fractions are separated to give one product (referred to as Mixture B) which comprises diglycerides, triglycerides and phytosterol and/or phytostanol esters of mainly saturated fatty acids and a second product (referred to as Mixture C) which comprises diglycerides, triglycerides and phytosterol and/or phytostanol esters of mainly unsaturated.
Further according to the invention, the content of phytosterol and/or phytostanol esters in Mixtures B and C may optionally further enriched. Importantly, the present invention enables the enrichment of any naturally occurring oil with sterol-esters and diacylglycerols.
The said Mixtures B and C can be subjected to further enrichment steps of the phytosterol and/or phytostanol esters contained in each layer.
In a further embodiment, the fractionation process of the invention comprises the enrichment of said Mixture A, to give a variety new mixtures, as follows:
These varied mixtures of phytosterol esters can be useful in a wide scope of applications such as, for example, in the food industry, both as a final product such as a dietary nutrient, and as a functional ingredient in alimentary products and as a food supplement.
As mentioned, the mixtures of the invention can also be prepared by simple blending ot diglyceride(s) and phytosterol or phytostanol ester(s) in edible oil and/or fat. Thus the invention further provides various blends of diglyceride(s) and phytosterol or phytostanol ester(s) in edible oil and/or fat. In accordance with the invention, these blends may contain 1-99 wt % phytosterol or phytostanol ester(s), 1-99 wt % diglycerides and no or up to 50 wt % monoglycerides, preferably 3-50 wt % diglycerides and 7-48 wt % phytosterol or phytostanol esters.
The ability to prepare a composition in which the type of phytosterol and/or phytostanol ester(s) is pre-determined is of great importance. More specifically, according to the present invention it is possible to prepare a composition in which the phytosterol and or phytostanol ester(s) in the composition are pre-determined by adding the desired phytosterol(s) and/or phytostanol(s) to a particular oil and/or fat during the esterification process. The separation, following the esterification process, of the oil and paste-like fractions provides a composition consisting of mainly the desired phytosterol and/or phytostanol ester(s), containing unsaturated fatty acid residues and/or a composition consisting of mainly the desired phytosterol and/or phytostanol ester(s) containing saturated fatty acid residues. The triglycerides in the oil and/or fat may serve as an internal source for fatty acyl group(s) in the phytosterol and/or phytostanol esterification process. Alternatively, or additionally, free fatty acid(s) and/or their derivatives may serve as an external source for acyl groups.
The purification and enrichment processes of the invention can also provide highly purified phytosterol and/or phytostanol esters.
The composition and nutrients of the invention may be formulated in dosage unit forms. For example, orally administrable dosage forms may be a tablet or capsule. Each dosage unit for oral administration may contain the recommended daily amount of a mixture of the invention, or parts or multiplications thereof. The recommended dose is usually determined by the attending physician or dietician, and would depend on the age, sex, weight and general condition of the prospective consumer.
For the preparation of tablets, any pharmaceutical carrier routinely used for preparing solid formulations may be used, for example, magnesium stearate, starch, terra alba, talc, gelatin, acacia, stearic acid, lactose and sucrose. For the preparation of capsules, any routine encapsulation is suitable, for example using the said carriers in a hard gelatin capsule shell. Soft gelatin shell capsules may also be prepared by using any pharmaceutical carrier routinely used for preparing dispersions or suspensions, such as aqueous gums, celluloses, silicates or oils, which can be incorporated in a soft gelatin capsule shell.
It is to be noted that in the description herein the terms diglycerides and diacylglycerols, are used interchangingly, and so are the terms phase and fraction, and paste, paste-like and spread.
Disclosed and described, it is to be understood that this invention is not limited to the particular examples, process steps, and materials disclosed herein as such process steps and materials may vary somewhat. It is also to be understood that the terminology used herein is used for the purpose of describing particular embodiments only and not intended to be limiting since the scope of the present invention will be limited only by the appended claims and equivalents thereof.
It must be noted that, as used in this specification and the appended claims, the singular forms “a”, “an” and “the” include plural referents unless the content clearly dictates otherwise.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise”, and variations such as “comprises” and “comprising”, will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The following Examples are representative of techniques employed by the inventors in carrying out aspects of the present invention. It should be appreciated that while these techniques are exemplary of preferred embodiments for the practice of the invention, those of skill in the art, in light of the present disclosure, will recognize that numerous modifications can be made without departing from the intended scope of the invention.
Methods
(1) Preparation of Products: Mixture A and Fractions B and C
Mixture A is defined as the mixture obtained following either direct esterification and/or alcoholysis+interesterification of phytosterols and/or phytostanols in oil in the presence of either free fatty acids and/or the corresponding mono-, di- or tri-glycerides. For example:
Reaction is carried out batch wise. Surfactant-coated immobilized lipase and phytosterols or plant stanols are added to the oil or fat. Typical mixture contains: 1 -10 parts of oil for 1 part of catalyst and 1 -10 parts of oil for 1 part of phytosterol (or plant stanol). The reaction mixture is then mixed and heated to 35-70° C., preferably 50-60° C. for 5-96 hrs, preferably 10-48 hrs. Conversion of phytosterols or phytostanols to phytosterol esters or phytostanol esters is determined by gas chromotograph. Weighed samples of reaction mixture (without catalyst) are taken from batch and diluted in n-hexane or toluene to concentrations of 20-60 mg/ml and injected directly to the GC according to method described below. Concentration of free phytosterols or phytostanols is determined quantitatively (according to calibration curves) and conversion is calculated relatively to initial concentrations of phytosterols. The reaction is usually stopped at conversion of 70-100%, typically 85-95%.
Mixture A will, therefore, contain phytosterol esters and the residue of free phytosterols that did not undergo esterification.
In addition, mixture A resulting from reaction between phytosterols and natural fat or oil will contain diglycerides, monoglycerides and some concentration of free fatty acids. Enrichment in diglycerides and monoglycerides is achieved through the “donation” of fatty acids from triglycerides to the phytosterol esters formation.
At the end of the reaction the catalyst is removed from the oil by hot filtration at reaction temperature. After cooling to room temperature or bellow, the obtained Mixture A forms a solid liquid slurry with two visibly distinct and separate phases (also referred to as fractions):
The two phases are distinct by the type of phytosterol esters they contain. The oil phase (fraction C) is enriched with esters of unsaturated fatty acids, such as, for example, oleic, linoleic and linolenic acids, whereas the spread phase (fraction B) is enriched with esters of saturated fatty acids, such as for example, palmitic and stearic acids.
Separation of mixture A to fraction B and fraction C can be obtained by centrifugation of mixture A for 5-60 minutes, preferably 10-30 minutes at 3,000-14,000 g and 10-25° C.
Fraction B is obtained in its paste-like form as the bottom phase and fraction C is obtained as clear oil as the top phase.
Leaving fraction C at room temperature for 1-10 days may result in further residual precipitation of paste and loss of oil clarity. Clear form will be obtained by a second centrifugation or by filtration.
Examples of natural oils and fats are plant and vegetable oils (linseed oil, rapeseed oil, corn oil, olive oil, cocoa butter, rice brain oil, soybean oil, palm oil, kernel oil, castor oil, cotton seed oil, coconut oil, peanut oil, sunflower oil, and the like), animal oils (butterfat, fish oil and the like).
Examples of phytosterols and phytostanols are beta-sitosterol, campesterol, stigmasterol and brassicasterol, and stigmasterol, campestanol and sitostanol.
Gas Chromatography
The concentrations of phytosterols, phytostanols, phytosterol esters, phytostanol esters, fatty acids and triglycerides were determined by a gas chromatograph, HP-5890, equipped with a flame ionization detector. A capillary column, Quardex 400-1HT was used under the following separation conditions: injector and detector temperatures were maintained at 350° C., initial column temperature 160° C., followed by a 2 min. isotherm; thereafter, the oven temperature was raised at a rate of 5° C./min to 180° C.; thereafter, the oven temperature was raised at a rate of 20° C./min to 400° C., followed by a 10 min. isotherm.
Further Understanding of the Fractionation Between Mixtures B and C
In order to further learn the fractionation to B and C mixtures reaction was conducted with various types of oils varying by the fatty acids compositions. For each oil source, reaction as described above is conducted and fractions B, C are separated and weighed.
Table 1 presents the weight percentages of the oily fraction (B) and the spread fraction (C) obtained from esterification reaction of phytosterols with soybean source in different oils. Reaction was conducted in shaker incubator at 50° C. for 24 hours, with phytosterols:oil weight ratio of 1:9 and catalyst:oil weight ratio of 1:5.
*Standard triolein purity > 99%-Sigma
**Epax 2050- “Pronova”
***Commercial refined sources
****Extra virgin Olive Oil
From Table 1 it is clearly shown that the mass fraction of the spread phase (mixture B) increases with the increase of saturated fatty acids ratio in the fatty acids source: the oil in this case.
In addition, mixture A and fractions B and C are further analyzed to evaluate the differences in the composition of fatty acids in the phytosterol esters molecules.
Purification of phytosterol esters from the mixture is achieved by glass column chromatography using Merck's silica gel 60 (0.04-0.063 μm) and Petroleum ether: ether mixture (2-10% of ether) as solvent. At this separation system phytosterol esters elute first and are easy to purify. Fractions containing phytosterol esters were combined and fatty acids in the pure phytosterol esters fraction, were transferred to methyl esters by applying AOC's method Ce-2-66. Separation and quantitation of methyl esters was performed on capillary gas chromatography using internal standard.
Table 2 presents the fatty acid composition of selected vegetable oils as reference to the fraction results.
Tables 3-5 present the fatty acids composition of mixtures A,B, and C mixtures resulting from reactions with different types of oils.
SFA designates saturated fatty acids, MUFA designates monounsaturated fatty acid and PUFA designates polyunsaturated fatty acids. The reaction conditions are similar to the described for Table 1.
The data presented in Tables 2-5 indicates the following:
Further enrichment of the reaction product with diglycerides and phytosterol esters can be obtained by introducing molecular distillation. The three main components are distilled over in an order according to their molecular weight: first the diglycerides, then the phytosterol esters and then the triglycerides. Therefore, varying feed stream composition and distillation conditions can lead to a predicted, diglycerides and phytosterol esters enriched distillate and triglycerides enriched residue. Distillation conditions of 0.001-0.01 mbar, preferably 0.001-0.005 mbar and 200-300° C., preferably 220-280° C., enable a distillation of the 2 lighter components: diglycerides and phytosterol esters.
4.2 Enrichment of Fractions B and C with Phytosterol Esters by Crystallization
Due to the relatively low solubility and high melting point of phytosterol esters comparing to other components in product, dissolving fractions in various organic solvents followed by cooling stage leads to a selective crystallization of phytosterol esters. This process enables an increase in phytosterol esters concentration.
Organic solvents that can be used are hexane, toluene, acetone, ethanol, methanol and others.
1.1 Enzymatic Reaction
The lipase-catalyzed conversion of stigma sterol to stigma sterol ester in canola oil was performed using the following reaction conditions:
9 g of a lipase preparation obtained according to WO 01/75083 were added to 50 ml canola oil enriched with 4 gr stigmasterol. The reaction mixture was then heated to 60° C. for 14 hours. Following this period, samples were taken, diluted with n-hexane (30 μl reaction mixture/600 μl n-hexane) and injected into a gas chromatography system, as described above. The concentration of unreacted stigmasterol was determined according to GC and conversion was calculated as 94%.
1.2 Separation of the Reaction Products
At the end of the reaction the enzyme was filtered and the mixture was cooled to 25° C. and left for 12 hrs.
The obtained mixture (herein referred to as Mixture A) has two distinct separated phases/fractions: an oil phase/fraction and a spread (paste-like) phase/fraction.
Mixtures B and C are obtained by centrifugation of Mixture A for 5 minutes, at 8000×rpm at about 15° C.
2.1 The Enzymatic Reaction
100 g of a lipase preparation obtained according to WO 01/75083 and 120 g of phytosterols from soybean source (containing 0.3-4% Brassicasterol, 20-30% Campasterol; 11-20% Stigmasterol; >40% Beta Sitosterol) were added to 450 g extra virgin olive oil in a 1 liter glass stirred reactor. The reaction mixture is then heated to 50° C. and stirred for 24 hours. Conversion of reaction was 93%. The catalyst is separated by filtration at 50° C. The filtered catalyst is added to a fresh mixture of 450 g extra virgin olive oil with 120 gr of unreacted phytosterols. The 2nd batch reaches 93% conversion after 24 hrs as well. Filtration of catalyst is repeated and 566 g of product (mixture A) are left at room temperature for 20 hrs.
Mixtures B and C are obtained by centrifugation of Mixture A for 15 minutes, at 7,500×g and 25° C.
Mixture B, the spread fraction, was of 164 gr weight, whereas mixture C, the oil fraction, weighed 402 gr.
The composition of mixture A was: 16.3% diglycerides, 6.18% monoglycerides, 30.5% phytosterol esters and 5% free fatty acids and balance of triglycerides.
Fatty acid compositions of phytosterol esters from fractions B and C were determined as described above. Results are presented in Table 6.
A reaction mixture obtained from canola oil source containing: 13 wt % phytosterol esters, 20 wt % diglycerides, 0.1-1 wt % of free phytosterols and 5 wt % free fatty acids was fed to a molecular still (glass made, 2 inch diameter, lab unit). First pass was conducted at conditions enabling removal of free phytosterol and free fatty acids: 180-200° C. and 0.01-0.001 mbar. Residue of first pass was fed again under different conditions that enable a variety of distillate compositions, as shown in Tables 7 and 8. PSE designates phytosterol esters.
In order to obtain above 90% of phytosterol esters in the distillate phase the necessary conditions were found to be: 260-265° C. and 0.001-0.005 mbar.
Calculations were done based on the feed mass balance and relative integrated area obtained from GC.
(i) For concentrating the phytosterol ester content in Mixture C, 100 ml of acetone were added to 100 ml Mixture C obtained as described under Example 2 above. The mixture was cooled to −20° C. for 12 hours. During this period a white solid precipitation (Mixture C1) was deposited from the oily mixture. The solid precipitation (25 g) was filtered in a cold filtration process and was washed few times with cold acetone.
(ii) For further concentrating the phytosterol ester content in Mixture C, 50 ml of toluene were added to 20 g solid Mixture C, obtained as described above, under mild heating. The mixture was cooled to −20° C. for 12 hours. During this period a white solid precipitate (Mixture C2) was deposited from the solution. The solid precipitation (4 g) was filtered in a cold filtration process and was washed few times with cold toluene.
(i)For concentrating the phytosterol ester content in Mixture B, 100 ml of hexane were added to 90 g Mixture B obtained as described in Example 2. The mixture was cooled to −20° C. for 12 hours. During this period a white solid precipitate (Mixture B1) was deposited from the solution. The solid precipitate (35 g) was filtered in a cold filtration process and was washed few times with cold hexane.
(ii)For further concentrating the phytosterol ester content in Mixture B, 50 ml of toluene were added to 20 g solid Mixture B, obtained as described in Example 2, under mild heating. The mixture was cooled to −20° C. for 12 hours. During this period a white solid precipitate (Mixture B2) was deposited from the solution. The solid precipitate (5 g) was filtered in a cold filtration process and was washed few times with cold toluene.
Number | Date | Country | Kind |
---|---|---|---|
147942 | Jan 2002 | IL | national |
The present application is a continuation of International Application PCT/IL03/00081 filed Jan. 30, 2003, the contents of which are here incorporated by reference in their entirety; the benefits of 35 USC Sec.120 are claimed.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/IL03/00081 | Jan 2003 | US |
Child | 10888087 | Jul 2004 | US |